We will have limited operations from 15:00 Wednesday 24 December 2025 (AEDT) until Friday 2 January 2026. Find out how to contact us during the holiday period.
Sponsor content
60 result(s) found, displaying 11 to 20
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for IQIRVO elafibranor 80 mg film-coated tablets bottle.
-
Prescription medicine registrationActive ingredients: odevixibat, odevixibat sesquihydrate.
-
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for RELFYDESS relabotulinumtoxinA 100 units/mL solution for injection vial.
-
Australian public assessment report (AusPar)Sohonos (palovarotene) was approved to treat heterotopic ossification in individuals with fibrodysplasia ossificans progressiva.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for SOHONOS palovarotene 10 mg capsule blister pack.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for SOHONOS palovarotene 5 mg capsule blister pack.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for SOHONOS palovarotene 1.5 mg capsule blister pack.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for SOHONOS palovarotene 1 mg capsule blister pack.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for SOHONOS palovarotene 2.5 mg capsule blister pack.